Churg Strauss Syndrome Market Research Report – Forecast to 2027

Churg Strauss Syndrome Market, by Diagnosis (Blood Test, Imaging, Biopsy), by Treatment (Biologics, Immunoglobulin, Corticosteroid, Immunosuppressive Drug, and Others), End-Users (Hospitals, Clinics, Laboratories, Therapeutics Aspects, and Others)

ID: MRFR/Pharma/4923-HCR | September 2022 | Region: Global | 100 Pages         

Churg Strauss Syndrome Market Scenario


The churg Strauss syndrome market is expected to grow during the forecast period (2018 to 2023) at a CAGR of ~ 4.1 %.

Churg Strauss syndrome is a disorder that causes inflammation in blood vessels. This restricts the blood flow to vital organs and tissues. Sometimes it leads to permanent damage of tissues. This condition is also known as eosinophilic granulomatosis with polyangiitis. Asthma is the most common sign of churg Strauss syndrome. It also affects nose, sinuses, lung, heart, and nerves. There are no medications on this and while it is rare some people got this disease because of asthma medication called Montelukast. As due to change in environmental conditions lots of people are suffering from allergic and immune disorders. Hence this leads to an increase in the growth of this market.

Factors such as growing occurrences of churg Strauss syndrome and other allergic reactions and asthma, rising geriatric population, and growing incidences of churg Strauss syndrome in children are expected to drive the growth of the market during the assessment period.

On the other hand, the unfavorable reimbursement scenario in many developing countries and lack of awareness regarding autoimmune disorder in people can hinder the growth of the market during the forecast period.

Segmentation

The churg Strauss syndrome market is segmented on basis of diagnosis, treatment, end users. Based on diagnosis the churg Strauss syndrome market is further segmented into blood test, imaging, biopsy, chest x-ray, CT scan. On basis of treatment, the syndrome is further segmented into biologics, immunoglobulin, corticosteroid, immunosuppressive drugs and others. Immunoglobulin is further sub-segmented into vaccines, steroids, and others. Based on end users the churg Strauss syndrome is further segmented into hospitals, clinics, laboratory, therapeutics aspects, and others.

Key players

Some of the key players in the global churg Strauss syndrome market are Slivergate, Heron Therapeutics, Inc., IRX Therapeutics, Inc., Brabourne Enterprises Ltd, Rupus Research Alliance, Tianjin Tianyao Pharmaceuticals Co., Ltd, and Grifols, S.A.

Regional Market Summary

Churg Strauss Syndrome Global Market Share, by Region, 2018 (%)


Churg Strauss Syndrome Market Share


Source: MRFR Analysis


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The churg Strauss syndrome market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East and Africa has been segmented into the Middle East and Africa.

Geographically, the Americas is anticipated to dominate the global churg Strauss syndrome market. The market growth in this region is attributed to the increasing asthma patients, change in environmental conditions, increasing allergic reaction and others. Moreover, the increasing incidence of asthma in the aging population is expected to fuel the growth of the market in this region. 

Europe is expected to be the second largest market in the globe owing to the increasing number of hay fever, increasing government expenditure for sinus pain and inflammation, increasing number of people visiting a doctor for allergic reaction problem.

Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of immunosuppressant disease and hyper-eosinophilia related problems in developing countries and increasing incidences of granulomatosis.  

The Middle East and Africa is expected to account for the lowest market share in the global churg Strauss syndrome market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.

Global Churg Strauss Syndrome Market, by Diagnosis


  • Blood test

  • Imaging

  • Biopsy

  • Chest X-ray

  • CT Sca


Global Churg Strauss Syndrome Market, by treatment



  • Biologics

  • Immunoglobulin

  • Vaccines

  • Steroid

  • Other

  • Corticosteroid

  • Immunosuppressive drugs

  • Others


Global Churg Strauss Syndrome Market, by End-User



  • Laboratories

  • Hospitals

  • Clinics

  • Therapeutic usage


Global Churg Strauss Syndrome Market, by Region


Americas

  • North America

  • US

  • Canada

  • South America


Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Hospitals and clinics

  • Laboratories and associations

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Government associations

  • Market research and consulting



Report Scope:

Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2018-2023: ~ 4.1%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Treatment, End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Slivergate, Heron Therapeutics, Inc., IRX Therapeutics, Inc., Brabourne Enterprises Ltd, Rupus Research Alliance, Tianjin Tianyao Pharmaceuticals Co., Ltd, and Grifols, S.A.
  Key Market Opportunities   Research and Development
  Key Market Drivers

  • Growing occurrences of churg Strauss syndrome and other allergic reactions and asthma
  • Rising geriatric population
  • Growing incidences of churg Strauss syndrome in children


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Churg strauss syndrome market would achieve 4.1% CAGR during the forecast period.

    Lack of reimbursement strategy and awareness can deter the churg strauss market growth.

    Churg strauss market includes segments like blood test, imaging, biopsy, chest x-ray, and CT scan.

    The treatment type includes immunoglobulin, biologics, immunosuppressive drugs, corticosteroid, and others.

    The end users are hospitals, laboratory, clinics, therapeutic aspects, and others.